Open original FDA record ↗Recall record
- FDA identifier
- Z-0386-2014
- Company in FDA record
- Lin-Zhi International Inc
- FDA classification date
- Nov 25, 2013
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class III
Reason stated in the source
Product catalog # A68825 Norbuprenorphine 13 ng/mL Level 2 Controls gives a decreased concentration reading due to the degradation of the NBUP analyte in solution.
Source facts
- Action
- Beckman Coulter sent a Manufacturer Field Action Letter dated November 2013, to the one distributor. The letter identified the product the problem and the action needed to be taken by the customer. Please share this information with your laboratory staff and retain this notification as part of your laboratory Quality System documentation. If you have forwarded any of the affected product(s) listed above to another laboratory, please provide them a copy of this letter. If you have any questions regarding this notice, please contact our Customer Support Center Via our website, http://www.beckmancoulter.com/customersupport/support Via phone, call 1-800-854-3633 in the United States Outside the United States, contact your local Beckman Coulter Representative. We apologize for any inconvenience.
- Initiated
- 2013-10-03
- Root cause
- Under Investigation by firm
- Terminated
- 2013-12-26
- Distribution
- US Distribution in CA.
- Recall number
- Z-0386-2014
- Recall status
- Terminated
- CDRH record ID
- 122570
- FDA classified
- 2013-11-25
- Recall event number
- 66542